Insights

Providing the latest information from our experts at Forge
January, 31 2024 in Articles
Comprehensive Characterization of Plasmid and AAV Gene Therapy Products with Forge Biologics’ Hybrid Sequencing Approach

Comprehensive characterization of plasmid and AAV gene therapy products with Forge...

December, 14 2023 in
Scaling to New Heights: Robust Scale Up to Commercial Manufacturing

Scaling to New Heights: Robust Scale Up from Shake Flask to Commercial AAV Manufacturing...

November, 14 2023 in Videos
23 Questions With Keerthana Subramanian

23 Questions with Keerthana Subramanian

October, 17 2023 in Articles
Starting With the End in Mind

Starting With the End in Mind

September, 11 2023 in Videos
23 Questions With Claire Marasco

23 Questions with Claire Marasco

April, 3 2023 in
Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography Platform

Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography...

December, 1 2022 in Articles
Streamline the AAV Manufacturing Process with High-Grade Starting Materials

 Streamline the AAV Manufacturing Process with High-Grade Starting Materials Authors:

November, 3 2022 in Articles, Videos
What the DMF! Spotlight on Forge's Drug Master File

Gene therapy developers' Investigational New Drug (IND) application process is arduous...